1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel - long-term follow-up
(
- Contribution to journal › Article
- 2003
-
Mark
A systematic overview of radiation therapy effects in uterine cancer (corpus uteri)
(
- Contribution to journal › Article
-
Mark
A systematic overview of radiation therapy effects in cervical cancer (cervix uteri)
(
- Contribution to journal › Article
-
Mark
A systematic overview of radiation therapy effects in ovarian cancer
(
- Contribution to journal › Article
- 2002
-
Mark
Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum
(
- Contribution to journal › Article
- 1998
-
Mark
A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis
(
- Contribution to journal › Article
-
Mark
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer : the Nordic experience
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(12). p.1301-1307(
- Contribution to journal › Article
- 1997
-
Mark
Nytt, dyrare medel mot ovarialcancer. Ar det värt sitt pris?
(
- Contribution to journal › Article
- 1996
-
Mark
Doxorubicin-melphalan with and without cisplatin in advanced ovarian cancer--ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group
(
- Contribution to journal › Article
- 1995
-
Mark
Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting : the Nordic experience. The Nordic Antiemetic Trial Group
(
- Contribution to journal › Article